The drug and device companies own the FDA and it is the companies’ profit potential that rules the review and approval process – except when the profit motive is overridden by the White House morality police, as with the morning-after pill.

That could not be explained by anything other than plain, old-fashioned sex discrimination,

Most studies submitted to the FDA have been conducted by the manufacturers of implants who obviously have a vested interested and whose findings are frequently biased and misleading. We must reform this heavy reliance on industry, which interferes with sound scientific decision-making by the FDA.

Whether it's Vioxx or Bextra or silicone implants, the rule now is 'Buyer Beware,' ... The drug and device companies own the FDA and it is the companies' profit potential that rules the review and approval process - except when the profit motive is overridden by the White House morality police, as with the morning-after pill.

There's a lot of potential in the market, and it's important to get the trading rules set.

The market is looking forward to signs of accelerating profit growth, which could add potential to stocks.